AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: AbbVie (HUMIRA) (humira.com)
A high-substance pharmaceutical site that prioritizes clinical data and regulatory safety disclosures over marketing hyperbole. The low BS score reflects the heavy oversight and requirement for forensic proof inherent in the pharmaceutical industry.
Fix the empty H1 tag on the homepage to clearly state the brand and primary indication for better SEO and accessibility. Implement Organization and Person schema to formally link AbbVie and medical leadership to the website’s claims. Consolidate the navigation-based ‘Leaving AbbVie’ H2 tags into a single modal to clean up the heading hierarchy. Update copyright and study dates to 2025 or 2026 to avoid the ‘aging’ content penalty as current data approaches the 36-month stale threshold.
The site exhibits high substance density, particularly in the body sections detailing trial outcomes like the 36% remission rate in Crohn’s patients. While the hero text ‘Reimagine Possible’ is a value prop cliché, it is immediately followed by specific nouns and indications. Power words are largely absent from the H3 markers, which are used strictly for functional safety warnings like ‘IMPORTANT SAFETY INFORMATION.’ Specific technical metrics, such as the 40 mg every other week dosing protocols, provide substantial evidence for the medication’s application and move the site far beyond marketing fluff.
If your @id chain is broken, your entire knowledge graph collapses into isolated nodes. Check your AI visible entity graph with a free one page structured data interpretation.
The homepage promises information about a biologic medication across several indications like Rheumatoid Arthritis and Crohn’s, and the sub-pages maintain perfect alignment. Sub-pages for Rheumatoid Arthritis and Psoriasis provide specific dosing protocols and exact trial outcomes, such as the 63% improvement rate in RA patients. There is no disconnect between the brand promise and the technical data provided on deep pages. The site successfully transitions from high-level condition overviews to granular technical specifications without shifting target audiences or value propositions.
Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.
The site avoids all trust theatre patterns by displaying a review_count of 0 and focusing exclusively on clinical evidence. Performance claims are backed by proof_links_count of 2 on sub-pages, leading to full prescribing information and FDA medication guides. The use of ‘Reference 1’ in headings anchors clinical claims to specific package inserts, providing a clear proof path that is verifiable by healthcare professionals.
The proof density is exceptional, with a high ratio of verifiable clinical data to unsubstantiated marketing assertions. On the Crohn’s page, specific remission rates (36% vs 12%) and symptom relief percentages (58% vs 34%) provide granular, dated evidence. Every performance claim is tied to the primary reference of the HUMIRA package insert, establishing a transparent and forensic evidence base.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site relies on a standard pharmaceutical template that prioritizes mandatory legal disclaimers and safety information. Matches for industry jargon include technical deliverables like ‘biologic medication’ and ‘clinical trial data,’ which are used in a substantive context. The value proposition is clearly differentiated around the specific brand entity, although the ‘What is HUMIRA?’ heading structure is a common industry template fingerprint. The repeated ‘Leaving AbbVie Web Site’ H2 blocks are generic regulatory requirements rather than unique value-add content.
Authority is primarily institutional through the AbbVie brand, but there is a notable absence of Person schema or named medical experts in the crawl. The technical implementation is slightly degraded by a missing H1 on the homepage and repetitive H2 tags for external link disclaimers. The schema_json being null suggests a missed opportunity to leverage structured data to verify the organization’s expertise and digital footprint.
Performance claims are highly regulated and substantiated by numerical trial data, preventing any marketing disconnect. For instance, the site claims more people saw 20% improvement in RA at 6 months and backs this with a specific chart reference. The site uses appropriate cautionary language, stating that ‘individual results may vary’ and providing comprehensive safety data alongside efficacy claims.
Medical Devices, Pharma & Biotech BS: AbbVie (HUMIRA) (humira.com)
The site perfectly matches the Medical and Pharmaceutical category, specifically targeting biologic therapies. All content is focused on the prescription medication adalimumab and its clinical indications for chronic inflammatory conditions.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score of 16 is driven by the extreme density of clinical data and the total absence of trust theatre (zero review counts without verification). Points were only added due to the absence of structured data schema and technical errors in heading hierarchy like the missing H1 and repetitive disclaimer H2s. Commodity fingerprint scores were minimized because technical jargon was used for functional clinical descriptions.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at AbbVie (HUMIRA) to view the most current version of their content and see directly what the company offers.